<bill session="109" type="s" number="2665" updated="2013-07-19T20:36:43-04:00">
  <state datetime="2006-04-27">REFERRED</state>
  <status>
    <introduced datetime="2006-04-27"/>
  </status>
  <introduced datetime="2006-04-27"/>
  <titles>
    <title as="introduced" type="short">Medicare Prescription Drug Simplification Act of 2006</title>
    <title as="introduced" type="official">A bill to amend title XVIII of the Social Security Act to simplify and improve the Medicare prescription drug program.</title>
  </titles>
  <sponsor id="300005"/>
  <cosponsors>
    <cosponsor id="300026" joined="2006-04-27"/>
    <cosponsor id="300057" joined="2006-04-27"/>
    <cosponsor id="300068" joined="2006-04-27"/>
    <cosponsor id="300100" joined="2006-04-27"/>
  </cosponsors>
  <actions>
    <action datetime="2006-04-27">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S3710-3711"/>
    </action>
    <action state="REFERRED" datetime="2006-04-27">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" activity="Referral, In Committee"/>
  </committees>
  <relatedbills>
    <bill relation="unknown" session="109" type="h" number="5102"/>
    <bill relation="unknown" session="109" type="h" number="5116"/>
    <bill relation="unknown" session="109" type="h" number="5263"/>
    <bill relation="unknown" session="109" type="s" number="2255"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Access to health care"/>
    <term name="Administrative remedies"/>
    <term name="Coinsurance"/>
    <term name="Commerce"/>
    <term name="Congress"/>
    <term name="Congressional investigations"/>
    <term name="Congressional reporting requirements"/>
    <term name="Consumer education"/>
    <term name="Drug therapy"/>
    <term name="Drug utilization"/>
    <term name="Drugs"/>
    <term name="Economics and public finance"/>
    <term name="Federal advisory bodies"/>
    <term name="Federal aid to health facilities"/>
    <term name="Federal-state relations"/>
    <term name="Finance and financial sector"/>
    <term name="Generic drugs"/>
    <term name="Government operations and politics"/>
    <term name="Government paperwork"/>
    <term name="Government trust funds"/>
    <term name="Governmental investigations"/>
    <term name="Health care fraud"/>
    <term name="Health counseling"/>
    <term name="Health insurance"/>
    <term name="Law"/>
    <term name="Licenses"/>
    <term name="Marketing"/>
    <term name="Medicare"/>
    <term name="Performance measurement"/>
    <term name="Pharmacies"/>
    <term name="Prescription pricing"/>
    <term name="Social welfare"/>
  </subjects>
  <amendments/>
  <summary>4/27/2006--Introduced.
Medicare Prescription Drug Simplification Act of 2006 - Revises the Medicare prescription drug program under part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act. Directs the Secretary of Health and Human Services to establish five national uniform benefit packages consisting of three basic and two supplemental packages. Limits removal or change of coverage of covered part D drugs under a formulary under a prescription drug plan (PDP) or an Medicare Advantage Prescription Drug (MA-PD) plan. Provides for: (1) additional funding for enrollment assistance; (2) comparative plan information; (3) a standardized definition for cost and utilization management tools, and nomenclature for distinguishing between excluded and nonformulary drugs; (4) standardized enrollee notice regarding coverage determinations; (5) standardized forms and processes for reconsiderations and exceptions; and (6) authority to waive late the enrollment penalty in certain circumstances. Directs the Secretary, jointly with the Commissioner of Social Security, to work to integrate processes and beneficiary information for applying for a premium and cost-sharing subsidy and enrolling in a PDP or an MA-PD plan in order to simplify steps for part D eligible individuals who wish to participate in both.Outlines requirements for comparative information regarding performance of plans under Medicare part D. Specifies factors the Secretary shall use in determining whether, for plan approval purposes, a PDP and its sponsor demonstrate a satisfactory quality of performance.</summary>
</bill>
